Business
‘We do not have capacity’ to make the Novavax vaccine, says CSL – Sydney Morning Herald
Biotechnology giant CSL has dashed speculation it could make the Novavax coronavirus vaccine onshore at the same time as it produces AstraZeneca’s product.
“At the request of government we have carefully considered our ability to simultaneously manufacture the Novavax vaccine, but unfortunately we do not have the capacity or capability to manufacture two COVID-19 vaccines involving live viruses,” the spokeswoman said.
“CSL remains fully focussed on production of the AstraZeneca vaccine and anticipates that the first locally produced doses of the vaccine will be ready in the second quarter of 2021, subject to regulatory approval.”
A purchasing agreement…
-
Noosa News19 hours agoWounding investigation, Mooloolaba – Sunshine Coast
-
General17 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
Noosa News14 hours agoTwo people charged after Mooloolaba stabbing
-
Noosa News13 hours agoMaroons name Gehamat Shibasaki for State of Origin debut against Blues, Josh Papali’i returns